| PRAME | Preferentially expressed Antigen in Melanoma |
| CT130 | Cancer Testis Antigen 130 |
| MAPE | Melanoma Antigen Preferentially Expressed in tumours |
| OIP-4 | Opa-interacting protein 4 |
| CTA | Cancer/Testis Antigen |
| AML | Acute Myeloid Leukaemia |
| LRR | Leucine-Rich Repeats |
| RA | Retinoic Acid |
| MITF | Microphthalmia Transcription Factor |
| NMSC | Non-Melanoma Skin Cancer |
| MCC | Merkel Cell Carcinoma |
| DEJ | Dermal–Epidermal Junction |
| SCC | Squamous Cell Carcinoma |
| BCC | Basal Cell Carcinoma |
| SUM | Subungual Melanoma |
| AM | Acral Melanoma |
| SMP | Subungual Melanocytic Proliferation |
| AST | Atypical Spitz Tumour |
| CCS | Clear Cell Sarcoma |
| RBT | Retinoid-Based Therapy |
| CAR-T | Chimeric Antigen Receptor T cell |